A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.

7563 Background: Biopsy of the primary tumour for predictive testing is not always convenient nor possible and may incur both delays and complications. In a move towards blood based predictive test...